Nostos Genomics partners with genetic testing labs to turn data into genomic insights, aiming to give more people with genetic diseases a fast and clear diagnosis. Over 300 million people live with rare genetic diseases, and often the diagnostic journey takes more than 5 years with many remaining undiagnosed. New technology enables genetic testing for diagnosis and development of targeted therapies. Their CE-certified platform combines machine learning and synthetic biology to automate and scale mutation interpretation, allowing labs to diagnose more patients faster.

They envision helping people with genetic diseases to start a new journey by improving the accuracy, speed, and accessibility of genetic testing. The company's technology aims to provide the right information at the right time, empowering patients to make informed health decisions. They value transparency, kindness, personal responsibility, and encourage personal growth within their diverse and international team.